Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series

Māris Taube; Alise Alma Lesiņa

doi:10.3389/fpsyt.2024.1514428

Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series

Māris Taube (Corresponding Author), Alise Alma Lesiņa

Department of Psychosomatic Medicine and Psychotherapy

Research output: Contribution to journal › Article › peer-review

1 Downloads (Pure)

Abstract

Severe acute respiratory sindrome - Coronavirus - 2 (SARS-CoV-2) (Coronavirus disease - 19 (COVID-19)) infection can result in long-term health consequences, such as long COVID. The clinical manifestations of long COVID include depression, anxiety, brain fog with cognitive dysfunction, memory issues, and fatigue. However, the links between vaccination and psychiatric disorders have been less studied. This article describes three patients who reported anxiety after receiving a complete course of the Pfizer-BioNTech BNT162b2 vaccine. It is important to explore the relationship between anxiety, other mental health disorders, and COVID-19 vaccination, as well as to investigate potential pathogenetic mechanisms.

Original language	English
Article number	1514428
Journal	Frontiers in Psychiatry
Volume	15
DOIs	https://doi.org/10.3389/fpsyt.2024.1514428
Publication status	Published - 2024

Keywords*

COVID-19 vaccines
SARS-CoV-2 vaccine
BioNTech162 vaccine
anxiety
case reports

Field of Science*

3.3 Health sciences
3.5 Other medical sciences
3.2 Clinical medicine

Publication Type*

1.1. Scientific article indexed in Web of Science and/or Scopus database

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fpsyt.2024.1514428Licence: CC BY

Development of anxietyFinal published version, 285 KBLicence: CC BY

Cite this

@article{dd4ed085ebf348bb84bb96cee5fc360c,

title = "Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series",

abstract = "Severe acute respiratory sindrome - Coronavirus - 2 (SARS-CoV-2) (Coronavirus disease - 19 (COVID-19)) infection can result in long-term health consequences, such as long COVID. The clinical manifestations of long COVID include depression, anxiety, brain fog with cognitive dysfunction, memory issues, and fatigue. However, the links between vaccination and psychiatric disorders have been less studied. This article describes three patients who reported anxiety after receiving a complete course of the Pfizer-BioNTech BNT162b2 vaccine. It is important to explore the relationship between anxiety, other mental health disorders, and COVID-19 vaccination, as well as to investigate potential pathogenetic mechanisms.",

keywords = "COVID-19 vaccines, SARS-CoV-2 vaccine, BioNTech162 vaccine, anxiety, case reports",

author = "Māris Taube and Lesiņa, {Alise Alma}",

note = "Publisher Copyright: Copyright {\textcopyright} 2025 Taube and Lesiņa.",

year = "2024",

doi = "10.3389/fpsyt.2024.1514428",

language = "English",

volume = "15",

journal = "Frontiers in Psychiatry",

issn = "1664-0640",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Case report

T2 - Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series

AU - Taube, Māris

AU - Lesiņa, Alise Alma

PY - 2024

Y1 - 2024

N2 - Severe acute respiratory sindrome - Coronavirus - 2 (SARS-CoV-2) (Coronavirus disease - 19 (COVID-19)) infection can result in long-term health consequences, such as long COVID. The clinical manifestations of long COVID include depression, anxiety, brain fog with cognitive dysfunction, memory issues, and fatigue. However, the links between vaccination and psychiatric disorders have been less studied. This article describes three patients who reported anxiety after receiving a complete course of the Pfizer-BioNTech BNT162b2 vaccine. It is important to explore the relationship between anxiety, other mental health disorders, and COVID-19 vaccination, as well as to investigate potential pathogenetic mechanisms.

AB - Severe acute respiratory sindrome - Coronavirus - 2 (SARS-CoV-2) (Coronavirus disease - 19 (COVID-19)) infection can result in long-term health consequences, such as long COVID. The clinical manifestations of long COVID include depression, anxiety, brain fog with cognitive dysfunction, memory issues, and fatigue. However, the links between vaccination and psychiatric disorders have been less studied. This article describes three patients who reported anxiety after receiving a complete course of the Pfizer-BioNTech BNT162b2 vaccine. It is important to explore the relationship between anxiety, other mental health disorders, and COVID-19 vaccination, as well as to investigate potential pathogenetic mechanisms.

KW - COVID-19 vaccines

KW - SARS-CoV-2 vaccine

KW - BioNTech162 vaccine

KW - anxiety

KW - case reports

UR - http://www.scopus.com/inward/record.url?scp=85216742691&partnerID=8YFLogxK

U2 - 10.3389/fpsyt.2024.1514428

DO - 10.3389/fpsyt.2024.1514428

M3 - Article

C2 - 39911555

SN - 1664-0640

VL - 15

JO - Frontiers in Psychiatry

JF - Frontiers in Psychiatry

M1 - 1514428

ER -

Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series

Abstract

Keywords*

Field of Science*

Publication Type*

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this